Bristol-Myers Squibb revenue and financials
$59.59Change from previous close: +1.33%Absolute change: +$0.78
In the fiscal year ended December 2025, Bristol-Myers Squibb reported revenue of $48.19B (−0.22% year over year). Net income was $7.05B, a net margin of 14.6%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −0.22%
- 2025 vs 2024
- Net margin
- 14.6%
- 2024: -18.5%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 87,634 | 86,476 | 90,038 | 96,889 | 94,676 | 92,427 | 92,603 | 93,670 | 94,646 | 99,031 | 95,159 | 91,263 |
| Current assets | 28,579 | 27,208 | 29,390 | 35,630 | 33,222 | 30,783 | 29,780 | 28,075 | 26,890 | 28,669 | 31,770 | 27,632 |
| Cash and equivalents | 8,722 | 9,574 | 10,209 | 15,726 | 12,599 | 10,875 | 10,346 | 7,890 | 6,293 | 9,330 | 11,464 | 7,514 |
| Short-term investments | 2,345 | 912 | 464 | 776 | 1,004 | 907 | 513 | 204 | 360 | 340 | 816 | 171 |
| Receivables | 13,000 | 12,081 | 14,526 | 14,616 | 15,102 | 14,586 | 14,424 | 14,895 | 15,146 | 14,060 | 15,264 | 15,647 |
| Inventory | 2,737 | 2,756 | 2,690 | 2,758 | 2,737 | 2,666 | 2,557 | 3,332 | 3,077 | 2,985 | 2,662 | 2,436 |
| Net property, plant and equipment | 9,277 | 9,186 | 9,125 | 8,953 | 8,649 | 8,428 | 8,360 | 8,251 | 8,161 | 8,186 | 8,036 | 7,848 |
| Goodwill | 21,740 | 21,740 | 21,754 | 21,745 | 21,776 | 21,737 | 21,719 | 21,751 | 21,732 | 21,738 | 21,169 | 21,147 |
| Other intangible assets | 17,387 | 18,244 | 19,103 | 20,465 | 21,378 | 22,486 | 23,307 | 26,964 | 29,428 | 32,760 | 27,072 | 28,950 |
| Long-term investments | 2,387 | 2,241 | 2,492 | 2,342 | 2,052 | 2,030 | 2,056 | 2,431 | 2,357 | 2,226 | 2,063 | 1,882 |
| Current liabilities | 18,659 | 19,158 | 23,417 | 28,136 | 27,528 | 24,070 | 23,774 | 22,638 | 23,265 | 25,822 | 22,262 | 23,462 |
| Accounts payable | 4,158 | 4,234 | 3,575 | 4,288 | 5,427 | 4,002 | 3,602 | 3,469 | 3,751 | 3,539 | 3,259 | 2,813 |
| Long-term debt | 42,093 | 42,152 | 42,898 | 44,469 | 44,530 | 46,181 | 47,640 | 48,711 | 48,884 | 49,535 | 36,696 | 32,193 |
| Total debt | 45,053 | 46,428 | 47,139 | 51,041 | 50,929 | — | — | — | — | — | — | — |
| Total liabilities | 65,315 | 66,374 | 71,532 | 78,289 | 77,187 | 74,979 | 76,215 | 76,470 | 77,577 | 82,483 | 65,674 | 62,201 |
| Total equity (incl. minority) | 22,319 | 20,102 | 18,506 | 18,600 | 17,489 | 17,448 | 16,388 | 17,200 | 17,069 | 16,548 | 29,485 | 29,062 |
| Retained earnings | 20,316 | 18,287 | 16,896 | 17,093 | 16,154 | 16,106 | 14,912 | 16,097 | 16,103 | 15,640 | 28,766 | 28,218 |
| Minority interest | 0.0 | 34.0 | 33.0 | 48.0 | 54.0 | 59.0 | 53.0 | 58.0 | 54.0 | 58.0 | 55.0 | 64.0 |
